Review finds disparity in presumptive chlamydia and gonorrhea treatment rates despite CDC guidelines

A Regenstrief Institute-led review of studies on proactive health services for chlamydia and gonorrhea has found that rates of presumptive treatment—antibiotics prior to laboratory test confirmation—varies widely.
A Regenstrief Institute-led review of studies on proactive health services for chlamydia and gonorrhea has found that rates of presumptive treatment—antibiotics prior to laboratory test confirmation—varies widely.